Kaplan-Meier survival analysis of the TCGA breast cancer dataset showed the overall survival time did not significantly differ between patients with high CBX6 expression and low CBX6 expression when bifurcating gene expression at the median (HR = 0.94, P = 0.61) (Fig. 1C). Here, CBX6 is linked to breast carcinoma.